In our two-part report, IQVIA Asia-Pacific presents an overview of the rare disease landscape in the Asia-Pacific (APAC) region.

In the previous version, Part 1 – Rare Diseases in APAC: The Unmet Potential, we examine the burden of rare disease in the APAC region, the level of maturity regarding rare disease care delivery in various APAC markets, and the potential size of these markets.

In this version, Part 2: Unlocking Solutions for Rare Diseases in APAC, we look at current challenges in rare disease management, potential solutions, and innovations in the rare disease space.

Authors:

Puneet Singh
Consultant

Rijul Bhardwaj
Associate Principal

Devaraj Subramaniam
Associate Principal, Consulting Services